Linda Book

NPI: 1033298609
Total Payments
$16,171
2024 Payments
$10,455
Companies
6
Transactions
27

Payment Breakdown by Category

Consulting$14,706 (90.9%)
Food & Beverage$1,245 (7.7%)
Travel$220.75 (1.4%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $14,706 7 90.9%
Food and Beverage $1,245 16 7.7%
Travel and Lodging $220.75 4 1.4%

Top Paying Companies

Company Total Records Latest Year
Mirum Pharmaceuticals, Inc. $15,680 19 $0 (2024)
Alexion Pharmaceuticals, Inc. $359.77 4 $0 (2018)
Sirtex Medical Inc $79.59 1 $0 (2018)
ACADIA Pharmaceuticals Inc $23.46 1 $0 (2023)
BeiGene USA, Inc. $19.25 1 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2024 $10,455 15 Mirum Pharmaceuticals, Inc. ($10,455)
2023 $2,298 2 Mirum Pharmaceuticals, Inc. ($2,275)
2022 $2,950 3 Mirum Pharmaceuticals, Inc. ($2,950)
2021 $19.25 1 BeiGene USA, Inc. ($19.25)
2018 $185.53 2 Alexion Pharmaceuticals, Inc. ($105.94)
2017 $263.03 4 Alexion Pharmaceuticals, Inc. ($253.83)

All Payment Transactions

27 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
08/03/2024 Mirum Pharmaceuticals, Inc. Livmarli (Drug) Consulting Fee Cash or cash equivalent $2,600.00 General
Category: Alagille syndrome
08/03/2024 Mirum Pharmaceuticals, Inc. Livmarli (Drug) Food and Beverage Cash or cash equivalent $116.46 General
Category: Alagille syndrome
08/03/2024 Mirum Pharmaceuticals, Inc. Livmarli (Drug) Travel and Lodging Cash or cash equivalent $95.75 General
Category: Alagille syndrome
08/03/2024 Mirum Pharmaceuticals, Inc. Livmarli (Drug) Food and Beverage Cash or cash equivalent $83.99 General
Category: Alagille syndrome
08/03/2024 Mirum Pharmaceuticals, Inc. Livmarli (Drug) Food and Beverage Cash or cash equivalent $69.64 General
Category: Alagille syndrome
08/02/2024 Mirum Pharmaceuticals, Inc. Livmarli (Drug) Consulting Fee Cash or cash equivalent $2,600.00 General
Category: Alagille syndrome
08/02/2024 Mirum Pharmaceuticals, Inc. Livmarli (Drug) Food and Beverage Cash or cash equivalent $143.48 General
Category: Alagille syndrome
08/02/2024 Mirum Pharmaceuticals, Inc. Livmarli (Drug) Food and Beverage Cash or cash equivalent $118.66 General
Category: Alagille syndrome
08/02/2024 Mirum Pharmaceuticals, Inc. Livmarli (Drug) Travel and Lodging Cash or cash equivalent $28.26 General
Category: Alagille syndrome
04/12/2024 Mirum Pharmaceuticals, Inc. Livmarli (Drug) Consulting Fee Cash or cash equivalent $2,600.00 General
Category: Alagille syndrome
04/12/2024 Mirum Pharmaceuticals, Inc. Livmarli (Drug) Consulting Fee Cash or cash equivalent $1,706.00 General
Category: Alagille syndrome
04/12/2024 Mirum Pharmaceuticals, Inc. Livmarli (Drug) Travel and Lodging Cash or cash equivalent $89.26 General
Category: Alagille syndrome
04/12/2024 Mirum Pharmaceuticals, Inc. Livmarli (Drug) Food and Beverage Cash or cash equivalent $86.00 General
Category: Alagille syndrome
04/12/2024 Mirum Pharmaceuticals, Inc. Livmarli (Drug) Food and Beverage Cash or cash equivalent $65.00 General
Category: Alagille syndrome
04/12/2024 Mirum Pharmaceuticals, Inc. Livmarli (Drug) Food and Beverage Cash or cash equivalent $52.29 General
Category: Alagille syndrome
04/29/2023 Mirum Pharmaceuticals, Inc. Livmarli (Drug) Consulting Fee Cash or cash equivalent $2,275.00 General
Category: Alagille syndrome
03/29/2023 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Food and Beverage In-kind items and services $23.46 General
Category: PARKINSONS DISEASE PSYCHOSIS
12/15/2022 Mirum Pharmaceuticals, Inc. Consulting Fee Cash or cash equivalent $975.00 General
08/17/2022 Mirum Pharmaceuticals, Inc. Livmarli (Drug) Food and Beverage In-kind items and services $25.22 General
Category: Alagille syndrome
05/02/2022 Mirum Pharmaceuticals, Inc. Consulting Fee Cash or cash equivalent $1,950.00 General
09/21/2021 BeiGene USA, Inc. BRUKINSA (Drug) Food and Beverage In-kind items and services $19.25 General
Category: Oncology
09/13/2018 Alexion Pharmaceuticals, Inc. Strensiq (Drug) Food and Beverage In-kind items and services $105.94 General
Category: Endocrinology
01/10/2018 Sirtex Medical Inc SIR-Spheres Microspheres (Device) Food and Beverage Cash or cash equivalent $79.59 General
Category: Interventional Oncology
10/24/2017 Alexion Pharmaceuticals, Inc. Kanuma (Drug) Food and Beverage In-kind items and services $125.00 General
Category: Immunology
09/19/2017 Retrophin, Inc. (820) Cholbam (Drug) Food and Beverage In-kind items and services $9.20 General
Category: Hepatology

About Linda Book

Linda Book is a Pediatric Gastroenterology healthcare provider based in Salt Lake City, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1033298609.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Linda Book has received a total of $16,171 in payments from pharmaceutical and medical device companies, with $10,455 received in 2024. These payments were reported across 27 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($14,706).

Practice Information

  • Specialty Pediatric Gastroenterology
  • Location Salt Lake City, UT
  • Active Since 11/03/2006
  • Last Updated 04/25/2022
  • Taxonomy Code 2080P0206X
  • Entity Type Individual
  • NPI Number 1033298609

Products in Payments

  • Livmarli (Drug) $12,755
  • Kanuma (Drug) $253.83
  • Strensiq (Drug) $105.94
  • SIR-Spheres Microspheres (Device) $79.59
  • NUPLAZID (Drug) $23.46
  • BRUKINSA (Drug) $19.25
  • (820) Cholbam (Drug) $9.20

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pediatric Gastroenterology Doctors in Salt Lake City